FDA Warning Letter for Your Supplement Brand? Protect Your Processor
An FDA warning letter can put a supplement company's merchant account at risk. Learn how to respond, talk to your processor and protect your payments.
Photo: Pixabay
On this page 8 sections
- How Processors Find Out About an FDA Warning Letter to a Supplement Company
- FDA Warning Letter vs. Untitled Letter vs. Cease-and-Desist
- Your Supplement Warning Letter Response: Fixing Claims, Labels, and Your Website
- Should You Tell Your Processor Before It Finds Out?
- Reserves, Reviews, and Processor Termination After an FDA Letter
- Handling Open Subscriptions and Refund Requests After a Letter
- Documenting Close-Out to Reassure Current and Future Processors
- Next Steps for Supplement Brands
Key takeaways
- Processor risk teams monitor public FDA and FTC letters, so your processor may learn about yours soon after it is published, possibly while you are still preparing your response.
- Fix every claim on your website, labels, retail displays, affiliate content and listings, then document each change with dates.
- Telling your processor early, with a written correction plan, usually goes better than waiting for its risk team to contact you.
- Never open new accounts under a different name or misdescribe your products to get around a freeze. That is misrepresentation, it violates card network rules, and it can make a recoverable situation permanent.
An FDA warning letter to a supplement company is a regulatory problem, and it can quickly become a payments problem too. Warning letters are typically published, and processor risk teams watch for them. Your merchant account can come under review while you are still working on your response to the agency. This guide explains how processors find out and how the different types of letters compare. It also covers what to fix first, whether to contact your processor, what reserves or termination might look like, how to handle subscriptions and refunds, and how to document your corrections so current and future processors can see the issue was resolved.
This article is general information, not legal or regulatory advice. An FDA or FTC letter calls for a qualified regulatory attorney. Use this guide for the payment side and your counsel for everything else.
How Processors Find Out About an FDA Warning Letter to a Supplement Company
Most acquirers already classify supplement brands as higher risk, and underwriting continues after approval. Risk teams monitor nutraceutical merchants on an ongoing basis. Common ways they spot a letter include:
- Public agency databases. FDA publishes warning letters on its website, and FTC announces many of its actions publicly. Risk teams and third-party monitoring vendors check these sources.
- Website and ad monitoring. Many processors use crawlers that scan merchant sites, product pages and ads for prohibited or high-risk claims. A letter that cites specific claims tells reviewers exactly where to look.
- Card network and sponsor bank scrutiny. Acquirers answer to their sponsor banks and the card networks. The networks pay extra attention to supplement sales involving health claims or "free trial" offers, so banks expect quick action when a regulator names a merchant.
- News, trade press and complaints. Industry coverage, consumer complaints and chargeback spikes can all prompt a manual review.
FDA generally posts warning letters some time after issuing them, so the timing varies. Assume your processor may learn about the letter soon after it is published, possibly while you are still preparing your response. Plan for that. An FDA warning letter becomes a merchant account issue once a risk reviewer sees it, whether or not you have finished your corrections.
FDA Warning Letter vs. Untitled Letter vs. Cease-and-Desist
The type of letter you received matters, both legally and for how a processor will read it. The table below is a general overview. Your attorney should confirm what your specific letter means.
| Letter Type | Typically From | General Meaning | How Processors Tend to View It |
|---|---|---|---|
| Warning letter | FDA, sometimes jointly with FTC | Agency believes there are significant violations and expects a written response and corrections | Serious; likely to trigger an account review |
| Untitled letter | FDA | Violations the agency considers less serious than those in a warning letter | Still a red flag if discovered; less likely to prompt immediate action |
| FTC warning letter | FTC | Concerns about advertising claims, substantiation or marketing practices | Serious for supplement sellers, especially with disease or weight-loss claims |
| Cease-and-desist | FTC, state attorneys general, or private parties such as competitors and trademark owners | Demand to stop a specific practice; legal weight varies widely by sender | Depends on the sender; a government cease-and-desist carries more weight |
FDA letters to supplement brands usually involve one or more of these issues:
- Disease claims. Marketing that presents a product as treating, curing or preventing a disease. These claims often appear in testimonials, blog posts or social media rather than on the label.
- Manufacturing findings. Problems identified during an inspection of manufacturing practices.
- Labeling and ingredient issues. These include ingredients the agency considers unlawful in dietary supplements.
An FDA untitled letter for supplements can sound minor. On the payment side, treat it as seriously as a warning letter, because a reviewer who finds it will ask the same questions.
Your Supplement Warning Letter Response: Fixing Claims, Labels, and Your Website
Your letter will state the response deadline. Put it on the calendar right away and work backward from it. The corrections you make in this window serve two audiences: the agency and your processor.
Inventory Every Place a Claim Lives
Regulators and risk teams look well beyond your homepage. Build a list that covers:
- Product pages, collection pages and checkout copy
- Blog posts, FAQs and "science" or "research" pages
- Customer reviews and testimonials you display or highlight
- Email and SMS marketing, including automated flows
- Social media posts, pinned content and bio links
- Affiliate, influencer and partner landing pages
- Marketplace listings and wholesale sell sheets
- Physical labels, packaging inserts and in-store materials such as shelf talkers, posters and counter cards
- Product descriptions in your POS or ecommerce catalog that appear on receipts or customer-facing screens
Correct, Archive and Date Everything
For each item, record the original wording, the corrected wording, the date of the change and who approved it. Save before-and-after screenshots. Ask affiliates in writing to take down or revise their content, and keep their confirmations.
Don't Forget Inventory and Labels
If the letter cites labels or ingredients, decide with counsel whether to relabel, quarantine or stop selling the affected stock. Your processor will want to know whether the flagged products are still for sale.
If you sell weight-management products, expect closer review. Our guide on why processors flag keto and fat-burner supplements explains what reviewers look for.
Should You Tell Your Processor Before It Finds Out?
In most cases, yes. Coordinate the timing with your attorney, but disclosing early usually works better than staying silent. Your merchant agreement may also require you to report regulatory actions. Read it, because failing to report can be grounds for termination on its own.
A risk team that finds the letter on its own has to assume the worst. A team that hears from you first, with a plan already in place, has something to take to the sponsor bank.
What to Send
| Item | Why It Helps |
|---|---|
| Copy of the letter | Shows you're not hiding anything |
| Summary of the cited issues | Gives the reviewer a quick picture without legal jargon |
| Corrective action plan with dates | Shows the problem is being fixed on a timeline |
| Before-and-after screenshots | Proves website and marketing changes |
| Name of your regulatory counsel | Signals the issue is being handled professionally |
| Status of affected products | Answers the "are you still selling it?" question |
Keep the message factual. Don't speculate about the outcome, argue the agency's findings with your processor or promise results you don't control.
Reserves, Reviews, and Processor Termination After an FDA Letter
An FDA warning letter will likely put your merchant account under review. Outcomes vary by processor, sponsor bank and the severity of the findings. Common responses include:
- Enhanced review. Requests for documentation, website changes and updated product lists.
- New or increased reserves. A portion of settlements held back to cover potential chargebacks and refunds. If reserves are new to you, read how a rolling reserve works and how to lower it.
- Delayed funding or temporary holds. Deposits held while the review is underway.
- Product restrictions. A requirement to stop processing payments for specific SKUs.
- Termination. The processor ends the relationship, usually holding funds for a period to cover disputes.
Understand the MATCH Risk
Some terminations lead to a merchant being added to Mastercard's MATCH database. A MATCH listing makes it much harder to open new accounts. It is one more reason to cooperate, respond quickly and keep chargebacks under control during a review.
What Not to Do
Opening accounts under a new business name, or describing your products differently on an application to hide your history, is misrepresentation. Running flagged sales through another merchant's account is transaction laundering. Both violate card network rules, and both can turn a recoverable situation into a permanent one. Our explainer on legal MID routing versus transaction laundering shows where the line is.
Handling Open Subscriptions and Refund Requests After a Letter
Recurring billing is where a regulatory problem most often turns into a chargeback problem. Customers who see news about a letter, or who bought because of a claim you've since removed, may dispute charges instead of asking you for a refund. If you sell trial offers, see our guide to Visa and Mastercard registration rules for nutra trial offers.
Review Your Active Subscriptions
- Flagged products. Decide with counsel whether to pause or cancel subscriptions for the affected products, or move those subscribers to other products. Don't keep billing for products you've stopped selling.
- Customer notice. Notify affected subscribers clearly and give them a simple way to cancel.
- Renewal terms. Confirm that your disclosures and cancellation flows meet the rules where your customers live. Our state-by-state automatic renewal law map is a good starting point. Confirm current requirements with counsel.
Make Refunds Easier Than Disputes
A refund costs you the sale. A chargeback costs you the sale plus a fee, and it adds a mark against your account while you're already under review. Our guide to structuring an empty-bottle money-back guarantee explains how to turn would-be chargebacks into refunds without inviting abuse. During this period:
- Answer refund requests quickly and generously, especially for flagged products.
- Show customer service contact details clearly on your site and in billing descriptors.
- Check dispute ratios weekly instead of monthly.
- Keep evidence organized for disputes you do need to fight. See our guide to winning "it didn't work" and trial chargebacks.
The same applies to in-person sales. Make sure store staff know the return policy for affected products, and confirm your POS can refund to the original card.
Documenting Close-Out to Reassure Current and Future Processors
Once the agency is satisfied with your corrective actions, it may issue a close-out letter. Timing varies, and not every matter ends with one. Either way, build a single file you can share with any processor or underwriter:
- The original letter and your written response
- Any follow-up correspondence with the agency, including a close-out letter if you receive one
- Your claim inventory with before-and-after records
- Affiliate takedown confirmations
- Updated labels, product lists and SKU status
- Your current marketing and claim-review procedures, including who approves new copy
- Recent chargeback and refund ratios showing stability
This file is useful well beyond your current processor. If you apply elsewhere, your regulatory history will usually come up in underwriting. A complete, honest record helps your application. Leaving the history off an application can lead to a decline or a later termination. Our guide to getting approved and staying live with a nutraceutical merchant account covers what underwriters typically ask for.
Next Steps for Supplement Brands
A warning letter doesn't have to end your ability to accept cards, but the first few weeks matter a great deal. Work through these steps in order:
- Bring in regulatory counsel and calendar the response deadline.
- Inventory and correct every claim, online and in-store.
- Tell your processor and send a written plan.
- Clean up subscriptions and make refunds easy.
- Build a close-out file you can share.
MannyPay works with nutraceutical and other higher-risk merchants through its nutraceutical merchant services and high-risk merchant accounts. Approval always depends on underwriting, and a merchant's regulatory history will be part of that review. To discuss your situation, request a free processing quote, and a MannyPay specialist will respond within one business day.
This article is for general educational purposes and is not legal, tax or financial advice. Card network rules and state laws change; confirm current requirements for your business.
